Mesenchymal stem cells stimulate antibody secretion in human B cells

被引:243
作者
Rasmusson, I. [1 ]
Le Blanc, K.
Sundberg, B.
Ringden, O.
机构
[1] Karolinska Univ Hosp Huddinge, Div Clin Immunol F79, Ctr Allogene Stem Cell Transplantat, SE-14186 Stockholm, Sweden
[2] Karolinska Inst, Div Clin Immunol, Stockholm, Sweden
关键词
D O I
10.1111/j.1365-3083.2007.01905.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mesenchymal stem cells (MSC) have immunomodulatory effects and inhibit T-cell responses to alloantigens and mitogens in vitro and in vivo. We wanted to examine the effect of MSC on human B cells. MSC stimulated IgG production, measured in an enzyme-linked immunospot (ELIspot) assay in blood and spleen lymphocytes. MSC only induced a low proliferation. When a semipermeable membrane separated MSC and mononuclear cells, the IgG production was stimulated in unfractionated lymphocytes. In contrast, enriched B cells required cell contact with MSC to produce IgG. Co-cultures of MSC and lymphocytes increased IFN-gamma production. MSC produce IL-6, and addition of MSC to spleen cells dramatically increased IL-6 levels. After lymphocyte stimulation with lipopolysaccharide (LPS), cytomegalovirus or varicella zoster virus, MSC either stimulated or inhibited IgG response, depending on the level of stimulation by LPS or the viral antigens. Similar results were obtained for enriched B cells. To conclude, MSC stimulate B-cell antibody secretion. The IgG secretion by activated B cells may be stimulated or inhibited by the addition of MSC, depending on the level of stimulation.
引用
收藏
页码:336 / 343
页数:8
相关论文
共 40 条
[31]   Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms [J].
Rasmusson, I ;
Ringdén, O ;
Sundberg, B ;
Le Blanc, K .
EXPERIMENTAL CELL RESEARCH, 2005, 305 (01) :33-41
[32]   BONE-MARROW TRANSPLANTATION IN THE RAT - LYMPHOCYTE-B ACTIVATION IN ACUTE GRAFT-VERSUS-HOST DISEASE [J].
RENKONEN, R ;
WANGEL, A ;
HAYRY, P .
TRANSPLANTATION, 1986, 41 (03) :290-296
[33]  
RINGDEN O, 1980, BLOOD, V55, P179
[34]   POLYCLONAL ANTIBODY SECRETION DURING ACUTE GRAFT-VERSUS-HOST DISEASE [J].
RINGDEN, O ;
SUNDBERG, B ;
MARKLING, L ;
TOLLEMAR, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 26 (05) :469-476
[35]   Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease [J].
Ringden, Olle ;
Uzunel, Mehmet ;
Rasmusson, Ida ;
Remberger, Mats ;
Sundberg, Berit ;
Lonnies, Helena ;
Marschall, Hanns-Ulrich ;
Dlugosz, Aldona ;
Szakos, Attila ;
Hassan, Zuzana ;
Omazic, Brigitta ;
Aschan, Johan ;
Barkholt, Lisbeth ;
Le Blanc, Katarina .
TRANSPLANTATION, 2006, 81 (10) :1390-1397
[36]   USE OF BACTERIA FOR FUNCTIONAL CHARACTERIZATION OF HUMAN LYMPHOCYTE SUB-POPULATIONS IN VARIOUS LYMPHOID ORGANS [J].
RYNNELDAGOO, B ;
RINGDEN, O ;
ALFREDSSON, H ;
MOLLER, E .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1978, 8 (05) :369-375
[37]   Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects [J].
Shake, JG ;
Gruber, PJ ;
Baumgartner, WA ;
Senechal, G ;
Meyers, J ;
Redmond, JM ;
Pittenger, MF ;
Martin, BJ .
ANNALS OF THORACIC SURGERY, 2002, 73 (06) :1919-1925
[38]  
SPLAWSKI JB, 1990, J IMMUNOL, V144, P562
[39]  
TOHMA S, 1991, J IMMUNOL, V146, P2544
[40]   The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity [J].
Wols, HAM ;
Underhill, GH ;
Kansas, GS ;
Witte, PL .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4213-4221